Poor prognosis of end-stage renal disease in systemic lupus erythematosus: A cohort of Chinese patients

Lupus

Volumn 12, Issue 11, 2003, Pages 827-832

  Lee, Po Tsang ^a,b,c   Fang, Hua Chang ^a,b   Chen, Chien Liang ^a   Chiou, Yee Hsuan ^a,b   Chou, Kang Ju ^a,b   Chung, Hsiao Min ^a,b  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Dialysis; End stage renal disease; Lupus nephritis; Mortality; Systemic lupus erythematosus

Indexed keywords

COMPLEMENT COMPONENT C3;

ADULT; ARTICLE; CHINESE; CLINICAL ARTICLE; COHORT ANALYSIS; COMPLEMENT BLOOD LEVEL; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; HEMODIALYSIS; HOSPITALIZATION; HUMAN; KIDNEY FAILURE; LENGTH OF STAY; LONG TERM CARE; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; MORTALITY; POPULATION RISK; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; SERODIAGNOSIS; STATISTICAL SIGNIFICANCE; SURVIVAL RATE; SURVIVAL TIME; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; COMPLEMENT SYSTEM PROTEINS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MALE; PROGNOSIS; RENAL DIALYSIS; SURVIVAL RATE;

EID: 0344875063     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1191/0961203303lu474oa     Document Type: Article

References (24)

1. Austin HA 3rd, Meunz LR, Joyce KM et al. Prognostic factors in lupus nephritis: contribution of renal histologic data. Am J Med 1983; 75: 382-391.
2. Goulet JR, Mackenzie T, Levinton C, Hayslett JP, Ciampi A, Esdaile JM. The longterm prognosis of lupus nephritis: the impact of disease activity. J Rheumatol 1993; 20: 59-65.
3. Ginzler EM, Diamond HS, Weiner M et al. A multicenter study of outcome in systemic lupus erythematosus: I. Entry variables as predictors of prognosis. Arthritis Rheum 1982; 25: 601-611.
4. Fries JF, Powers R, Kempson RI. Late-stage lupus nephropathy. JRheumatol 1974; 1: 166-175.
5. Coplon NS, Diskin CJ, Petersen J, Swenson RS. The long-term clinical course of systemic lupus erythematosus in end-stage renal disease. N Engl J Med 1983; 308: 186-190.
6. Jarrett MP, Santhanam S, Del Greco F. The clinical course of end-stage renal disease in systemic lupus erythematosus. Arch Intern Med 1983; 143: 1353-1356.
7. Cheigh JS, Stenzel KH. End-stage renal disease in systemic lupus erythematosus. Am J Kidney Dis 1993; 21: 2-8.
8. Kimberly RP, Lockshin MD, Sherman RL, Beary JF, Mouradian J, Cheigh JS. 'End-stage' lupus nephritis: clinical course to and outcome on dialysis. Experience with 39 patients. Medicine 1981; 60: 277-287.
9. Ziff M, Helderman JH. Dialysis and transplantation in end-stage lupus nephritis. N Engl J Med 1983; 308: 218-219.
10. Pollock CA, Ibels LS. Dialysis and transplanation in patients with renal failure due to systemic lupus erythematosus: the Australian and New Zealand experience. Aust NZ J Med 1987; 17: 321-325.
11. Nissenson AR, Port FK. Outcome of end-stage renal disease in patients with rare causes of renal failure: III. Systematic/vascular disorders. Q J Med 1990; 273: 63-74.
12. Krane NK, Buzjak K, Archie M, O'Donovan R. Persistent lupus activity in end-stage renal disease. Am J Kidney Dis 1999; 33: 872-879.
13. Bombardier C, Gladman DD, Urowitz MB, Caron D, Chang CH, and the Committee on Prognosis Studies in SLE. Deviation of the SLEDAI: A disease activity index for lupus patients. Arthritis Rheum 1992; 35: 630-640.
14. Nossent HC, Swaak TJG, Berden JHM, for the Dutch Working Party on SLE. Systemic lupus erythematosus. Analysis of disease activity in 55 patients with end-stage renal failure treated with hemodialysis or continuous ambulatory peritoneal dialysis. Am J Med 1990; 89: 169-174.
15. Bruce IN, Hallett DC, Gladman DD, Urowitz MB. Extrarenal disease activity in systemic lupus erythematosus is not suppressed by chronic renal insufficiency or renal replacement therapy. J Rheumatol 1999; 26: 1490-1494.
16. Okano K, Yumura W, Nitta K et al. Analysis of lupus activity in endstage renal disease treated by hemodialysis. Int Med 2001; 40: 598-602.
17. Pahl MV, Vaziri ND, Saiki JK, Upham T, Ness R. Chronic hemodialysis in end-stage lupus nephritis: Changes of clinical and serological activities. Int J Artif Organs 1984; 8: 423-428.
18. Hopkinson ND, Doherty M, Powell RJ. Clinical features and race-specific incidence/prevalence rates of systemic lupus erythematosus in a geographically complete cohort of patients. Ann Rheum Dis 1994; 53: 675-680.
19. Thumboo J, Uramoto K, O'Fallon WM et al. A comparative study of the clinical manifestations of systemic lupus erythematosus in Caucasians in Rochester, Minnesota, and Chinese in Singapore, from 1980 to 1992. Arthritis Rheum 2001; 45: 494-500.
20. Jarrett MP, Santhanam S, Del Greco F. The clinical course of end-stage renal disease in systemic lupus erythematosus. Arch Intern Med 1983; 143: 1353-1356.
21. Staples PJ, Gerding DW, Decker JL, Grodon RS Jr. Incidence of infection in systemic lupus erythematosus. Arthritis Rheum 1974; 17: 1-10.
22. Manzi S, Meilahn EN, Rairei JE et al. Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: Comparison with the Framingham Study. Am J Epidemiol 1997; 145: 408-415.
23. Ward MM. Premature morbidity from cardiovascular and cerebrovascular diseases in women with systemic lupus erythematosus. Arthritis Rheum 1999; 42: 338-346.
24. Ward MM. Cardiovascular and cerebrovascular morbidity and mortality among women with end-stage renal disease attributable to lupus nephritis. Am J Kidney Dis 2000; 36: 516-525.